You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Haemorrhoids and other anal conditions

Chronic anal fissure: 2% topical diltiazem hydrochloride

  • Evidence summary
  • Reference number: ESUOM3
  • Published:  22 January 2013
  • Advice
  • Information for the public
Download (PDF)
  • Key points from the evidence
  • Overview for healthcare professionals
  • Relevance to NICE guidance programmes
  • Interventions and alternatives
  • Evidence review: efficacy
  • Evidence review: safety
  • Evidence review: economic issues
  • Evidence strengths and limitations
  • Summary for patients
  • References
  • Development of this evidence summary
  • Appendix: Search strategy and evidence selection
  • Changes since publication
  • About 'Evidence summaries: unlicensed or off-label medicines'

Relevance to NICE guidance programmes

Topical diltiazem hydrochloride has not been assessed as part of a NICE technology appraisal work programme and is not currently listed as a proposed technology appraisal or an appraisal in development.

Constipation in children and young people (NICE clinical guideline 99) identifies anal fissure as a possible finding in children with constipation but does not discuss its treatment specifically.


Next page Interventions and alternatives Previous page Overview for healthcare professionals
Back to top